Amphastar Pharmaceuticals, Inc. filed an 8-K on November 11, 2026, announcing that CFO Bill Peters and EVP Jacob Liawatidewi will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 18, 2026.
Key Highlights
- Participants named: Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will represent the company at the event.
- Event format: The appearance is described as an analyst-moderated fireside chat at the Jefferies Global Healthcare Conference in London.
- Date and time: The session is scheduled for Wednesday, November 18, 2026, at 12:00 pm GMT.
- Webcast availability: A webcast of the presentation will be available for 30 days following the event, according to the filing.
- Exchange and ticker: Amphastar Pharmaceuticals trades on NASDAQ:AMPH.
Amphastar Executives Scheduled for London Healthcare Conference Fireside Chat
According to the filing, Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), headquartered in Rancho Cucamonga, California, disclosed that two senior executives will attend the Jefferies Global Healthcare Conference in London. CFO Bill Peters and EVP of Corporate Administration Jacob Liawatidewi are named as the company representatives participating in the analyst-moderated fireside chat on November 18, 2026, at 12:00 pm GMT.
The company describes itself in the filing as "a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products." The filing further notes that Amphastar also sells active pharmaceutical ingredients, referred to as API products, and that most of its finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers. Named proprietary brands referenced in the filing include BAQSIMI, Primatene MIST, Amphadase, and Cortrosyn.
The filing states that the webcast will remain accessible for 30 days following the presentation. The announcement also contains forward-looking statements, which the company characterizes as subject to known and unknown risks, uncertainties, and assumptions. Amphastar noted that it "undertakes no obligation to revise or update information or any forward-looking statements in this press release or the conference call referenced above to reflect events or circumstances in the future, even if new information becomes available or if subsequent events cause our expectations to change."
What Was Disclosed
Amphastar Pharmaceuticals disclosed the participation of CFO Bill Peters and EVP Jacob Liawatidewi in a Jefferies Global Healthcare Conference fireside chat in London on November 18, 2026, at 12:00 pm GMT, with webcast access available for 30 days after the event.



Please wait processing your request...